Cyclophosphamide Dose Weight Adjustment in Morbidly Obese With Lymphoma Is Safe and Yields Favorable Outcomes After Autologous Hematopoietic Cell Transplantation (HCT)
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.176
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2015
Authors
Publisher
Elsevier BV